Share Name Share Symbol Market Type Share ISIN Share Description
Sinclair Pharma LSE:SPH London Ordinary Share GB0033856740 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +1.275p +8.54% 16.20p 15.95p 16.20p 16.20p 14.75p 15.00p 1,382,121 16:20:13
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 45.3 -4.3 -0.0 - 81.61

Sinclair Pharma PLC Publication of Annual Report and Accounts

18/05/2018 8:00am

UK Regulatory (RNS & others)


Sinclair Pharma (LSE:SPH)
Historical Stock Chart

1 Month : From Apr 2018 to May 2018

Click Here for more Sinclair Pharma Charts.

TIDMSPH

RNS Number : 5450O

Sinclair Pharma PLC

18 May 2018

Sinclair Pharma plc

Publication of Annual Report and Accounts

London, 18 May 2018 Sinclair Pharma plc (SPH.L), ("Sinclair" or the "Company") the international aesthetics company, announces that its Annual Report and Accounts for the year ended 31 December 2017 is available at the Company's website, www.sinclairpharma.com and will be posted to shareholders shortly.

For further information please contact:

 
 Sinclair Pharma plc    Tel: +44 (0) 
                         20 7467 6920 
 Chris Spooner 
  Alan Olby 
  Andy Crane 
 
 Peel Hunt LLP (NOMAD   Tel: +44 (0) 
  and Joint Broker)      20 7418 8900 
 James Steel 
  Oliver Jackson 
 
 
 RBC Capital Markets    Tel: +44 (0) 
  (Joint Broker)         20 7653 4000 
 Marcus Jackson 
  Laura White 
 
 
 Media enquiries 
 FTI Consulting         Tel: +44 (0) 
                         203 727 1000 
 Ben Atwell 
  Brett Pollard 
 

Notes to Editors:

About Sinclair Pharma plc

Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, self-pay global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets, Brazil, South Korea and the US, and has a network of international distributors.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSAPMFTMBABMRP

(END) Dow Jones Newswires

May 18, 2018 03:00 ET (07:00 GMT)

1 Year Sinclair Pharma Chart

1 Year Sinclair Pharma Chart

1 Month Sinclair Pharma Chart

1 Month Sinclair Pharma Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:gb D:20180526 08:25:22